ERS International Congress 2021: highlights from Assembly 8 Thoracic Surgery and Lung Transplantation

103/250 Main body: 3670/5000 References: 55 Tables: 0 Figures: 0 Online Supplemental Material: no Reprint request: no reprints are requested ABBREVIATIONS AI artificial intelligence BOS bronchiolitis obliterans syndrome CT computed tomography ERS European Respiratory Society EVLP ex-vivo lung perfusion HITOC hyperthermic intrathoracic chemotherapy LAS lung allocation score LOS length of stay MPM malignant pleural mesothelioma OS overall survival PD-L1 programmed death-ligand 1 pmTNM pulmonary metastasis TNM (tumor-node-metastasis) staging PRO patient-reported outcomes PROMs patient-reported outcome measures PulMiCC pulmonary metastasectomy versus continued active monitoring in colorectal cancer RFS recurrence-free survival SAD small airways disease WSI whole slides images THM (256 char): The thoracic surgery and lung transplantation ERS assembly highlights sessions on digital health surveillance, novel developments in pulmonary metastasectomy, mesothelioma care, and lung graft allocation and monitoring, presented at the last ERS Congress.

[1]  M. Migliore,et al.  The second modification of a dedicated staging system for lung metastases. , 2021, Future oncology.

[2]  M. Kornaszewska,et al.  Hyperthermic intrathoracic chemotherapy in thoracic surgical oncology: future challenges of an exciting procedure. , 2021, Future oncology.

[3]  K. Rising,et al.  Medical Oncology Patient Perceptions of Telehealth Video Visits , 2021, JCO oncology practice.

[4]  David R. Jones,et al.  A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab. , 2021, Cancer discovery.

[5]  T. Järvinen,et al.  Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis , 2021, Cancers.

[6]  S. Keshavjee,et al.  Telerehabilitation for Lung Transplant Candidates and Recipients During the COVID-19 Pandemic: Program Evaluation , 2021, JMIR mHealth and uHealth.

[7]  S. Keshavjee,et al.  Interdisciplinary Approach to Comprehensive Virtual Patient Care in Lung Transplant , 2021 .

[8]  S. Withers,et al.  Developing Universal ABO Blood Type Donor Lungs with Ex Vivo Enzymatic Treatment: A Proof of Concept Feasibility Study , 2021 .

[9]  L. Fallowfield,et al.  Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Cohort Study: analysis of case selection, risk factors and survival in a prospective observational study of 512 patients. , 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[10]  A. Mansfield,et al.  First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial , 2021, The Lancet.

[11]  M. Ambrogi,et al.  Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma , 2021, Annals of translational medicine.

[12]  K. Rising,et al.  Medical Oncology Professionals’ Perceptions of Telehealth Video Visits , 2021, JAMA network open.

[13]  R. Cameron.  Reply: Discussions regarding pulmonary metastasectomy are similar to American politics: Both are extremely polarizing, unsatisfying, inconclusive, and undertaken at your own peril. , 2020, The Journal of thoracic and cardiovascular surgery.

[14]  Aaron M Williams,et al.  Surgery Provider Perceptions on Telehealth Visits During the COVID-19 Pandemic: Room for Improvement , 2020, Journal of Surgical Research.

[15]  N. Valsangkar,et al.  Association Between Patient Physical Function and Length of Stay After Thoracoscopic Lung Cancer Surgery. , 2020, Seminars in thoracic and cardiovascular surgery.

[16]  S. Blackmon,et al.  Image guided thermal ablation in lung cancer treatment , 2020, Journal of thoracic disease.

[17]  E. Abdelnour-Berchtold,et al.  Is repeated pulmonary metastasectomy justified? , 2020, Clinical & Experimental Metastasis.

[18]  C. Dirksen,et al.  Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review , 2020, Supportive Care in Cancer.

[19]  K. Franks,et al.  Patients' views of routine quality of life assessment following a diagnosis of early-stage non-small cell lung cancer. , 2020, Interactive cardiovascular and thoracic surgery.

[20]  M. Rosemann,et al.  Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC , 2020, Cancer Immunology, Immunotherapy.

[21]  M. Barr,et al.  Use of a Bluetooth tablet‐based technology to improve outcomes in lung transplantation: A pilot study , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  T. Kolevska,et al.  Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually. , 2020, JCO oncology practice.

[23]  J. Copeland,et al.  Donor heart and lung procurement: A consensus statement. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  G. Wainrib,et al.  Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  S. Keshavjee,et al.  Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion. , 2019, JAMA surgery.

[26]  J. Dunning,et al.  Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial , 2019, Trials.

[27]  G. Wainrib,et al.  Deep learning-based classification of mesothelioma improves prediction of patient outcome , 2019, Nature Medicine.

[28]  S. Flanagan,et al.  Fit 4 surgery, a bespoke app with biofeedback delivers rehabilitation at home before and after elective lung resection , 2019, Journal of Cardiothoracic Surgery.

[29]  G. Scagliotti,et al.  Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. , 2019, The Lancet. Respiratory medicine.

[30]  R. Blasczyk,et al.  Immunoengineering of the Vascular Endothelium to Silence MHC Expression During Normothermic Ex Vivo Lung Perfusion. , 2019, Human gene therapy.

[31]  H. Pass,et al.  Expert Consensus Document on Pulmonary Metastasectomy. , 2019, The Annals of thoracic surgery.

[32]  Yang Wang,et al.  A Meta-Analysis of Clinical Outcomes After Radiofrequency Ablation and Microwave Ablation for Lung Cancer and Pulmonary Metastases. , 2019, Journal of the American College of Radiology : JACR.

[33]  Clemens Scott Kruse,et al.  The use of Electronic Health Records to Support Population Health: A Systematic Review of the Literature , 2018, Journal of Medical Systems.

[34]  W. Vos,et al.  Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation. , 2018, Academic radiology.

[35]  Samuel G Armato,et al.  Deep convolutional neural networks for the automated segmentation of malignant pleural mesothelioma on computed tomography scans , 2018, Journal of medical imaging.

[36]  A. D’Incecco,et al.  Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study. , 2018, The Lancet. Respiratory medicine.

[37]  N. Tustison,et al.  Quantitative Computed Tomography Metrics From the Transplanted Lung can Predict Forced Expiratory Volume in the First Second After Lung Transplantation , 2017, Journal of thoracic imaging.

[38]  K. Franks,et al.  Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC). , 2017, Journal of thoracic disease.

[39]  Raúl San José Estépar,et al.  Quantitative computed tomography assessment of bronchiolitis obliterans syndrome after lung transplantation , 2017, Clinical transplantation.

[40]  A. Santoro,et al.  Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial. , 2017, The Lancet. Oncology.

[41]  H. Hermens,et al.  Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice , 2017, Journal of Cancer Survivorship.

[42]  S. Keshavjee,et al.  Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. , 2017, The Lancet. Respiratory medicine.

[43]  Olivier Molinier,et al.  Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial , 2016, The Lancet.

[44]  T. Egan,et al.  Effect of the lung allocation score on lung transplantation in the United States. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  M. Migliore,et al.  Looking forward lung metastasectomy-do we need a staging system for lung metastases? , 2016, Annals of translational medicine.

[46]  S. Solomon,et al.  Percutaneous ablation of colorectal lung metastases. , 2015, Journal of gastrointestinal oncology.

[47]  C. Chow,et al.  Outcomes of telehealth care for lung transplant recipients , 2015, Clinical transplantation.

[48]  A. Fisher,et al.  Ex vivo lung perfusion in clinical lung transplantation--state of the art. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[49]  W. Richards,et al.  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. , 2013, The Journal of thoracic and cardiovascular surgery.

[50]  Marcelo Cypel,et al.  Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.

[51]  P. Jänne,et al.  Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  N. Paul,et al.  Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance? , 2004, Radiology.

[53]  R. Fitzpatrick,et al.  Quality of life measurement: bibliographic study of patient assessed health outcome measures , 2002, BMJ : British Medical Journal.

[54]  S. Cykert,et al.  Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target? , 2000, Chest.

[55]  T. Treasure,et al.  Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice? , 2021 .

[56]  J. Gottlieb.  Lung allocation. , 2017, Journal of thoracic disease.